Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands
European Journal of Cancer · 2024-07 · 205 · 114125
DOI: 10.1016/j.ejca.2024.114125 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2024-07. Verfasst von V D de Jager und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- The Dutch Nationwide Pathology Databank (Palga), Houten, the Netherlands.
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Pathology, University Hospital Antwerp, University of Antwerp, Edegem,…
- Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: s.m.willems@umcg.nl.
Zitieren
APA
de Jager, V. D., Cajiao Garcia, B. N., Kuijpers, C. C. H. J., de Bock, G. H., Maas, W. J., Timens, W., van Kempen, L. C., van der Wekken, A. J., Schuuring, E., & Willems, S. M. (2024). Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands. European Journal of Cancer, 205, 114125. https://doi.org/10.1016/j.ejca.2024.114125
Vancouver
de Jager VD, Cajiao Garcia BN, Kuijpers CCHJ, de Bock GH, Maas WJ, Timens W, et al. Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands. European Journal of Cancer. 2024;205:114125. doi:10.1016/j.ejca.2024.114125
BibTeX
@article{deJager2024,
author = {de Jager, V D and Cajiao Garcia, B N and Kuijpers, C C H J and de Bock, G H and Maas, W J and Timens, W and van Kempen, L C and van der Wekken, A J and Schuuring, E and Willems, S M},
title = {Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands},
journal = {European Journal of Cancer},
year = {2024},
volume = {205},
pages = {114125},
doi = {10.1016/j.ejca.2024.114125}
}
EUVIMED